Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ProgynyPGNY +4.34%94 FCF Margin % is 12.06% as of Mar. 2026, which is 23% above its 10-year median of 9.80. GuruFocus rates PGNY with a GF Score™ of 94/100 and a GF Value™ of $28.40 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 18 Healthcare Plans companies, Progyny ranks better than 77.78% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Progyny's Free Cash Flow for the
three
months ended in Mar. 2026 was $40 Mil. Progyny's Revenue for the
three
months ended in Mar. 2026 was $329 Mil. Therefore, Progyny's FCF Margin % for the quarter that ended in Mar. 2026 was 12.06%.
The historical rank and industry rank for Progyny's FCF Margin % or its related term are showing as below:
PGNY'
s FCF Margin % Range Over the Past 10 Years
Min: -20.76 Med: 9.8 Max: 17.01
Current: 14.26
During the past 9 years, the highest FCF Margin % of Progyny was 17.01%. The lowest was -20.76%. And the median was 9.80%.
PGNY's FCF Margin % is ranked better than 77.78% of 18
companies
in the Healthcare Plans industry
Industry Median: 4.09
vs PGNY: 14.26
Progyny FCF Margin % Related Terms
Progyny FCF Margin % Historical Data
* Premium members only.
The historical data trend for Progyny's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Healthcare Plans subindustry, Progyny's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Progyny FCF Margin % vs Healthcare Plans Industry
For the Healthcare Plans industry and Healthcare sector, Progyny's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Progyny's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Progyny (PGNY) has a FCF Margin % of 12.06% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Progyny and its competitors. This is 23% above median its historical median of 9.80. According to the industry distribution chart, Progyny ranks #4 out of 18 companies in the Healthcare Plans industry, placing it in the top 22.2%.
Is Progyny's FCF Margin % too high?
Progyny's current FCF Margin % of 12.06% is 23% above median its 10-year median of 9.80. The Healthcare Plans industry median FCF Margin % is 4.09. Progyny's value of 12.06% is 194.9% above this industry median. Based on the distribution chart, Progyny ranks #4 out of 18 companies in the Healthcare Plans industry, which is in the top quartile — a strong position relative to peers. Overall, Progyny has a GF Score™ of 94/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Progyny's FCF Margin % compare to CLOV and PFHO?
According to the Healthcare Plans industry distribution chart, Progyny ranks #4 out of 18 companies for FCF Margin %. This places Progyny in the top 22% of its industry — outperforming the majority of peers. The industry median FCF Margin % is 4.09. Progyny's value of 12.06% is 194.9% above this benchmark. While the company's 10-year median is 9.80 vs. the industry median of 4.09, Progyny has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Healthcare Plans company?
The median FCF Margin % among Healthcare Plans companies is 4.09, based on 18 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Progyny's current FCF Margin % of 12.06% is 194.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Progyny and its competitors. For the Healthcare Plans industry, the median FCF Margin % is 4.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Progyny's current FCF Margin % is 12.06%, which is 23% above median its own 10-year median of 9.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Progyny stock overvalued right now?
Based on GuruFocus' analysis, Progyny (PGNY) is currently considered Modestly Overvalued. The stock's GF Value™ is $28.40, compared to a current price of $31.98 — trading 12.6% above its estimated fair value. The current FCF Margin % is 12.06%, which is 23% above median its 10-year median of 9.80 and 194.9% above the Healthcare Plans industry median of 4.09. Progyny's overall GF Score™ is 94/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Progyny (PGNY), the current FCF Margin % is 12.06% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Progyny (PGNY) Overvalued in 2026?
Based on GuruFocus' analysis, Progyny stock appears to be overvalued.
The current stock price of $31.98 is trading 12.6% above its estimated GF Value™ of $28.40.
GuruFocus considers Progyny to be Modestly Overvalued.
Key valuation signals for PGNY:
FCF Margin %: 12.06% (23% above median its 10-year median of 9.80)
GF Value™: $28.40 vs. price of $31.98 (12.6% above fair value)
Industry Position: 194.9% above the Healthcare Plans median (#4 of 18)
No single metric tells the full story. See the PGNY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.
94GF Score
Get the complete analysis for PGNY
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PGNY has been successfully added to your 
